Ignacio Tusquets

581 total citations
16 papers, 252 citations indexed

About

Ignacio Tusquets is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ignacio Tusquets has authored 16 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Ignacio Tusquets's work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (4 papers). Ignacio Tusquets is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (4 papers). Ignacio Tusquets collaborates with scholars based in Spain, Australia and Austria. Ignacio Tusquets's co-authors include Françesc Solé, Luis Cirera, Marta Salido, Josep Corominas, Àngels Arcusa, Ignasi Guasch, A. Balil, Eugeni Saigí, E. Batiste-Alentorn and Sérgio Serrano and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Ignacio Tusquets

16 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Tusquets Spain 9 131 110 59 50 50 16 252
Michele Pavarana Italy 9 115 0.9× 128 1.2× 84 1.4× 29 0.6× 20 0.4× 23 275
Nanfeng Fan China 9 112 0.9× 152 1.4× 33 0.6× 52 1.0× 53 1.1× 22 238
Matthias Schauer Germany 10 114 0.9× 178 1.6× 69 1.2× 95 1.9× 23 0.5× 24 332
Svetlana Tafjord Norway 5 282 2.2× 79 0.7× 52 0.9× 26 0.5× 46 0.9× 7 313
Zhixue Zheng China 10 185 1.4× 170 1.5× 27 0.5× 70 1.4× 48 1.0× 19 353
Liubin Shi China 13 118 0.9× 146 1.3× 109 1.8× 122 2.4× 29 0.6× 24 383
G. Maddalo Italy 9 74 0.6× 90 0.8× 93 1.6× 66 1.3× 55 1.1× 18 305
Taro Isobe Japan 10 139 1.1× 195 1.8× 71 1.2× 72 1.4× 37 0.7× 31 345
David Papadimos Australia 8 87 0.7× 70 0.6× 43 0.7× 62 1.2× 9 0.2× 11 205
Arinilda Campos Bragagnoli Brazil 6 159 1.2× 131 1.2× 26 0.4× 54 1.1× 44 0.9× 15 244

Countries citing papers authored by Ignacio Tusquets

Since Specialization
Citations

This map shows the geographic impact of Ignacio Tusquets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Tusquets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Tusquets more than expected).

Fields of papers citing papers by Ignacio Tusquets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Tusquets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Tusquets. The network helps show where Ignacio Tusquets may publish in the future.

Co-authorship network of co-authors of Ignacio Tusquets

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Tusquets. A scholar is included among the top collaborators of Ignacio Tusquets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Tusquets. Ignacio Tusquets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bosch, David D., et al.. (2020). Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?. Clinical & Translational Oncology. 23(1). 65–73. 11 indexed citations
2.
3.
Tusquets, Ignacio, Sònia Servitja, Miguel Ángel Seguí, et al.. (2014). Association Between Insulin Resistance (Ir) and Pathologic Complete Response (Pcr) to Neoadjuvant Chemotherapy (Nac) Among No Diabetic Women with Localized Infiltrating Breast Cancer (Libc). Annals of Oncology. 25. iv114–iv114. 1 indexed citations
4.
Tusquets, Ignacio, Sònia Servitja, Daniel Prieto‐Alhambra, et al.. (2014). Bone turnover markers at 3 months of aromatase inhibitor therapy for prediction of 1-year bone mineral density loss: The B-ABLE cohort.. Journal of Clinical Oncology. 32(15_suppl). 581–581. 1 indexed citations
5.
Álvarez, Isabel, Ignacio Tusquets, Miguel Ángel Seguí, et al.. (2012). Finding the right dose of fulvestrant in breast cancer. Cancer Treatment Reviews. 39(2). 136–141. 4 indexed citations
6.
Servitja, Sònia, Manuel Ramos, Miguel Gil Gil, et al.. (2011). Multicenter, phase II, nonrandomized study of docetaxel plus trastuzumab every 21 days as the primary therapy in metastatic breast cancer overexpressing HER2. Anti-Cancer Drugs. 23(2). 239–246. 7 indexed citations
7.
Égervári, Kristóf, Marta Salido, Federico Rojo, et al.. (2009). FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors. Breast Cancer Research. 11(2). 402–402. 23 indexed citations
8.
Mayordomo, José, José Manuel Baena, Luis Cirera, et al.. (2009). Final results of a randomized trial on the role of maintenance chemotherapy with weekly paclitaxel for patients with metastatic breast cancer. Journal of Clinical Oncology. 27(15_suppl). 1001–1001. 9 indexed citations
9.
Barco, Sonia Del, Rámón Colomer, Lourdes Calvo, et al.. (2008). Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial. Breast Cancer Research and Treatment. 116(2). 351–358. 8 indexed citations
10.
Haba-Rodríguez, Juan de la, Enrique Aranda, Antonio Llombart‐Cussac, et al.. (2007). Time-to-progression in breast cancer: A stratification model for clinical trials. The Breast. 17(3). 239–244. 2 indexed citations
11.
Bellosillo, Beatríz, Josep Corominas, Marta Salido, et al.. (2007). Does Polysomy of Chromosome 17 Have a Role in ERBB2 and Topoisomerase IIα Expression?. Tumor Biology. 28(4). 221–228. 15 indexed citations
12.
Corominas, Josep, Ignacio Tusquets, Marta Salido, et al.. (2006). The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma. Cancer Genetics and Cytogenetics. 165(2). 151–156. 36 indexed citations
13.
Bellosillo, Beatríz & Ignacio Tusquets. (2006). Pitfalls and Caveats in BRCA Sequencing. Ultrastructural Pathology. 30(3). 229–235. 8 indexed citations
14.
Tusquets, Ignacio, Marta Salido, Josep Corominas, et al.. (2005). Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry. Tumor Biology. 26(1). 25–30. 15 indexed citations
15.
Martín, Miguel, Antonio Llombart‐Cussac, Aňa Lluch, et al.. (2004). Estudio epidemiológico del grupo GEICAM sobre el cáncer de mama en España (1990-1993): proyecto «El Álamo». Medicina Clínica. 122(1). 12–17. 13 indexed citations
16.
Cirera, Luis, A. Balil, E. Batiste-Alentorn, et al.. (1999). Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer. Journal of Clinical Oncology. 17(12). 3810–3815. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Pavarana Breakdown of academic impact, for papers by Nanfeng Fan Breakdown of academic impact, for papers by Matthias Schauer Breakdown of academic impact, for papers by Svetlana Tafjord Breakdown of academic impact, for papers by Zhixue Zheng Breakdown of academic impact, for papers by Liubin Shi Breakdown of academic impact, for papers by G. Maddalo Breakdown of academic impact, for papers by Taro Isobe Breakdown of academic impact, for papers by David Papadimos Breakdown of academic impact, for papers by Arinilda Campos Bragagnoli
Rankless by CCL
2026